These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8949409)

  • 1. [Genetics of cardio-vascular complications of diabetes].
    Soubrier F
    Ann Endocrinol (Paris); 1996; 57(3):155-9. PubMed ID: 8949409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes].
    Mosorjáková D; Kyslanová L; Kozárová M; Tkác I
    Vnitr Lek; 2002 Aug; 48(8):749-54. PubMed ID: 12425206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy.
    Orisio S
    J Nephrol; 1999; 12(1):9-17. PubMed ID: 10202997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic basis of cardiovascular disease--the renin-angiotensin-aldosterone system as a paradigm.
    Padmanabhan N; Padmanabhan S; Connell JM
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):316-24. PubMed ID: 11967817
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polymorphism of the renin-angiotensin-aldosterone system: molecular and epidemiogenetic aspects].
    Soubrier F
    Nephrologie; 1998; 19(7):377-84. PubMed ID: 9857371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphism of the insertion/deletion type in the angiotensin-converting enzyme gene in normal subjects and among patients with vascular complications].
    Demurov LM; Chistiakov DA; Chugunova LA; Shamkhalova MSh; Shestakova MV; Anokhin EE; Kondrat'ev IaIu; Dedov II; Nosikov VV
    Mol Biol (Mosk); 1997; 31(1):59-62. PubMed ID: 9173248
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetics of cardiovascular disease in type 1 (insulin-dependent) diabetes with and without renal involvement.
    Rudberg S
    Nephrol Dial Transplant; 1997 Nov; 12(11):2217-9. PubMed ID: 9394300
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population.
    Ermis C; Tsai MY; Hanson NQ; Akar N; Aras O
    Thromb Haemost; 2002 Oct; 88(4):693-4. PubMed ID: 12362249
    [No Abstract]   [Full Text] [Related]  

  • 11. [The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease].
    Spiering W; Kroon AA; Vreugdenhil HA; Geraedts JP; Daemen MJ; de Leeuw PW
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1445-50. PubMed ID: 9752056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic risk factors for diabetic complications].
    Deutsch E; Vardi P; Shohat M
    Harefuah; 1997 Jun; 132(12):862-6. PubMed ID: 9264195
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of genetic studies in finding the etiopathogenesis of diabetes mellitus].
    Sieradzki J
    Przegl Lek; 2000; 57 Suppl 3():3-6. PubMed ID: 11293231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular diseases and gene polymorphisms].
    Bartosová L; Strnadová V; Bartos M; Krcmár J; Necas J
    Cas Lek Cesk; 2006; 145(9):695-700; discussion 700-1. PubMed ID: 17091724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between the angiotensin-converting-enzyme gene insertion/deletion polymorphism and the occurrence of macroangiopathy in patients with diabetes mellitus type 2.
    Klemm T; Mittrach-Schorin S; Neumann S; Gerike T; Krankenberg H; Schuler G; Paschke R
    Horm Metab Res; 2003 Jan; 35(1):43-7. PubMed ID: 12669270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of DNA polymorphism in the renin-angiotensin system and the pathogenesis of cardiovascular diseases].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1997; 51(2):171-83. PubMed ID: 9235564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes].
    Grzeszczak W
    Przegl Lek; 2000; 57 Suppl 3():19-24. PubMed ID: 11293230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease?
    van Geel PP; Pinto YM; Buikema H; van Gilst WH
    Eur Heart J; 1998 Jul; 19 Suppl G():G13-7. PubMed ID: 9717050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.